Congenital diarrhea in a newborn infant: A case report

Mehrin Sadiq1, Omer Choudry1, Arun K Kashyap1

  • 1Robert Wood Johnson University Hospital, Rutgers University, New Brunswick, NJ 08901, United States.

Abstract

Insights

Microvillus inclusion disease (MVID) is a rare cause of severe congenital diarrhea. This case report details a novel MYO5B gene mutation identified in an infant with MVID, emphasizing the need for genetic testing in diagnosing this challenging condition.

Area of Science:

  • Genetics
  • Pediatrics
  • Gastroenterology

Background:

  • Microvillus inclusion disease (MVID) is a rare autosomal recessive disorder causing severe congenital diarrhea, often leading to significant morbidity and mortality.
  • Diagnosis can be challenging, necessitating advanced genetic testing for identifying causative mutations.
  • Current definitive treatment for MVID is a bowel transplant.

Observation:

  • A case of an infant presenting with severe, unexplained diarrhea, failure to thrive, and metabolic derangements is described.
  • Extensive diagnostic work-up, including biopsies and stool studies, failed to establish a diagnosis.
  • The infant required total parenteral nutrition (TPN) due to persistent voluminous diarrhea unresponsive to various dietary interventions.

Findings:

  • Genetic testing revealed a novel homozygous mutation in the MYO5B gene (c.1462del, p. (Ile488Leufs*93)) in the infant.
  • This previously unreported mutation confirmed the diagnosis of Microvillus inclusion disease (MVID).
  • There are 232 known allelic variations of the MYO5B gene, highlighting the genetic complexity of MVID.

Implications:

  • This case underscores the importance of considering MVID in neonates with severe, intractable diarrhea.
  • Identification of novel mutations expands the understanding of MVID's genetic basis.
  • Early and accurate diagnosis through genetic testing is crucial for timely management and potential intervention, such as awaiting a bowel transplant.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
699
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
425
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.2K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
636